Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma

Annals of Surgical Oncology

Volumn 20, Issue 4, 2013, Pages 1230-1239

  Turaga, Kiran K ^a   Tsai, Susan ^a   Wiebe, Lauren A ^a   Evans, Douglas B ^a   Gamblin, T Clark ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 ETHYNYLURACIL; CA 19-9 ANTIGEN; CADHERIN; CAPECITABINE; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIN B1; CYCLIN DEPENDENT KINASE; DEATH ASSOCIATED PROTEIN KINASE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; FLUOROURACIL; GEMCITABINE; K RAS PROTEIN; KI 67 ANTIGEN; MITOMYCIN; MUCIN 4; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P16; PROTEIN P53; SMAD4 PROTEIN; STEM CELL FACTOR RECEPTOR; SURVIVIN; SYNDECAN 1; VASCULOTROPIN;

ADJUVANT CHEMOTHERAPY; BILE DUCT CARCINOMA; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CHEMORADIOTHERAPY; CONFERENCE PAPER; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; EXTRAHEPATIC CHOLANGIOCARCINOMA; GENE EXPRESSION; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MOLECULARLY TARGETED THERAPY; MONOTHERAPY; PANCREAS ADENOCARCINOMA; PROGNOSIS; RADIATION DOSE; SURVIVAL TIME;

ANTIMETABOLITES, ANTINEOPLASTIC; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BRACHYTHERAPY; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; FLUOROURACIL; HUMANS; LIVER TRANSPLANTATION; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SURVIVAL RATE;

EID: 84875203659     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2648-0     Document Type: Conference Paper

References (76)

1. WP Longmire MS McArthur EA Bastounis J Hiatt 1973 Carcinoma of the extrahepatic biliary tract Ann Surg. 178 333 345 4354116 10.1097/00000658- 197309000-00013 1:STN:280:DyaE3s3kvF2ktQ%3D%3D
2. Y Shaib HB El-Serag 2004 The epidemiology of cholangiocarcinoma Semin Liver Dis. 24 115 125 15192785 10.1055/s-2004-828889
3. G Klatskin 1965 Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features Am J Med. 38 241 256 14256720 10.1016/0002-9343(65)90178-6 1:STN:280:DyaF2M%2FmtFagsA%3D%3D
4. SA Khan SD Taylor-Robinson MB Toledano A Beck P Elliott HC Thomas 2002 Changing international trends in mortality rates for liver, biliary and pancreatic tumours J Hepatol. 37 806 813 12445422 10.1016/S0168-8278(02)00297-0
5. SA Khan HC Thomas BR Davidson SD Taylor-Robinson 2005 Cholangiocarcinoma Lancet. 366 1303 1314 16214602 10.1016/S0140-6736(05)67530-7
6. ACS. Bile Duct (Cholangiocarcinoma) Cancer 2011. http://www.cancer.org/ acs/groups/cid/documents/webcontent/003084-pdf.pdf. Accessed 17 July 2011.
7. DB Evans MB Farnell KD Lillemoe C Vollmer Jr SM Strasberg RD Schulick 2009 Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement Ann Surg Oncol. 16 1736 1744 19387741 10.1245/s10434-009-0416-6
8. DB Evans 2001 Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas J Gastrointest Surg. 5 2 5 11370617 10.1016/S1091-255X(01)80002-0 1:STN:280:DC%2BD3M3mvVOhtQ%3D%3D
9. R Roy A Maraveyas 2010 Chemoradiation in pancreatic adenocarcinoma: a literature review Oncologist. 15 259 269 20203172 10.1634/theoncologist.2009- 0272 1:CAS:528:DC%2BC3cXlsFClt7w%3D
10. DB Evans TA Rich DR Byrd KR Cleary JH Connelly B Levin, et al. 1992 Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas Arch Surg. 127 1335 1339 1359851 10.1001/archsurg.1992. 01420110083017 1:STN:280:DyaK3s%2FnsVertw%3D%3D
11. MH Katz H Wang JB Fleming CC Sun RF Hwang RA Wolff, et al. 2009 Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma Ann Surg Oncol. 16 836 847 19194760 10.1245/s10434-008-0295-2
12. JS Estrella A Rashid JB Fleming MH Katz JE Lee RA Wolf, et al. 2012 Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation Cancer. 118 268 277 21735446 10.1002/cncr.26243
13. S Satoi H Yanagimoto H Toyokawa K Takahashi Y Matsui H Kitade, et al. 2009 Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer Pancreas. 38 282 288 19142173 10.1097/MPA. 0b013e31819438c3 1:CAS:528:DC%2BD1MXjsVyqsbg%3D
14. H Golcher T Brunner G Grabenbauer S Merkel T Papadopoulos W Hohenberger, et al. 2008 Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy Eur J Surg Oncol. 34 756 764 18191528 10.1016/j.ejso.2007.11.012 1:STN:280:DC%2BD1czovVKitA%3D%3D
15. NM Chandler JJ Canete KE Stuart MP Callery 2003 Preoperative chemoradiation in resectable pancreatic cancer J Hepatobiliary Pancreat Surg. 10 61 66 12918459
16. S Gillen T Schuster 2010 Meyer Zum Buschenfelde C, Friess H, Kleeff J. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages PLoS Med. 7 e1000267 20422030 10.1371/journal.pmed.1000267
17. JM Herman MJ Swartz CC Hsu J Winter TM Pawlik E Sugar, et al. 2008 Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital J Clin Oncol. 26 3503 3510 18640931 10.1200/JCO.2007.15.8469
18. M Mohamadnejad JM DeWitt S Sherman JK LeBlanc HA Pitt MG House, et al. 2011 Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience Gastrointest Endosc. 73 71 78 21067747 10.1016/j.gie.2010.08.050
19. J Meza-Junco AJ Montano-Loza M Ma W Wong MB Sawyer VG Bain 2010 Cholangiocarcinoma: has there been any progress? Can J Gastroenterol. 24 52 57 20186357
20. LH Schwartz FV Coakley Y Sun LH Blumgart Y Fong DM Panicek 1998 Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography AJR Am J Roentgenol. 170 1491 1495 9609160 10.2214/ajr.170.6.9609160 1:STN:280:DyaK1c3ntVehsQ%3D%3D
21. H Seo JM Lee IH Kim JK Han SH Kim JY Jang, et al. 2009 Evaluation of the gross type and longitudinal extent of extrahepatic cholangiocarcinomas on contrast-enhanced multidetector row computed tomography J Comput Assist Tomogr. 33 376 382 19478630 10.1097/RCT.0b013e318184f3f7
22. T Okumoto A Sato T Yamada K Takase T Matsuhashi M Tsuda, et al. 2009 Correct diagnosis of vascular encasement and longitudinal extension of hilar cholangiocarcinoma by four-channel multidetector-row computed tomography Tohoku J Exp Med. 217 1 8 19155601 10.1620/tjem.217.1
23. Rouse RV. Surgical Pathology Criteria is focused on the presentation of useful diagnostic criteria in an accessible format 2011. http:// surgpathcriteria.stanford.edu/. Accessed 15 July 2011.
24. KM McMasters TM Tuttle SD Leach T Rich KR Cleary DB Evans, et al. 1997 Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma Am J Surg. 174 605 608 9409582 10.1016/S0002-9610(97)00203-1 1:CAS:528:DyaK1cXitFSktQ%3D%3D discussion 608-9
25. JW Nelson AP Ghafoori CG Willett, et al. 2009 Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma Int J Radiat Oncol Biol Phys 73 1 148 153 18805651 10.1016/j.ijrobp.2008.07.008 1:CAS:528:DC%2BD1cXhsFajsrbL
26. DJ Rea JK Heimbach CB Rosen MG Haddock SR Alberts WK Kremers, et al. 2005 Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma Ann Surg. 242 451 458 16135931 discussion 458-61
27. JK Heimbach GJ Gores DM Nagorney CB Rosen 2006 Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies? Surgery. 140 331 334 16934588 10.1016/j.surg.2006.01.010
28. D Sudan A DeRoover S Chinnakotla I Fox B Shaw Jr T McCashland, et al. 2002 Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma Am J Transplant. 2 774 779 12243499 10.1034/j.1600-6143.2002.20812.x
29. JC Hong CM Jones JP Duffy H Petrowsky DG Farmer S French, et al. 2011 Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center Arch Surg. 146 683 689 21690444 10.1001/archsurg.2011.116
30. CD Fuller SJ Wang M Choi BG Czito J Cornell TM Welzel, et al. 2009 Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis Cancer. 115 5175 5183 19637356 10.1002/cncr.24572
31. FM Serafini D Sachs M Bloomston LC Carey RC Karl MM Murr, et al. 2001 Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy Am Surg. 67 839 843 11565760 1:STN:280: DC%2BD3MrhvFSqsA%3D%3D discussion 843-4
32. S Kim SW Kim YJ Bang DS Heo SW Ha 2002 Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer Int J Radiat Oncol Biol Phys. 54 414 419 12243816 10.1016/S0360-3016(02)02952-8
33. ET Shinohara N Mitra M Guo JM Metz 2008 Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma Int J Radiat Oncol Biol Phys. 72 1495 1501 18472359 10.1016/j.ijrobp.2008.03.018
34. G Kopelson L Harisiadis P Tretter CH Chang 1977 The role of radiation therapy in cancer of the extra-hepatic biliary system: an analysis of thirteen patients and a review of the literature of the effectiveness of surgery, chemotherapy and radiotherapy Int J Radiat Oncol Biol Phys. 2 883 894 73534 10.1016/0360-3016(77)90186-9 1:STN:280:DyaE1c%2Fms1GntQ%3D%3D
35. TB Brunner D Schwab T Meyer R Sauer 2004 Chemoradiation may prolong survival of patients with non-bulky unresectable extrahepatic biliary carcinoma. A retrospective analysis Strahlenther Onkol. 180 751 757 15592694 10.1007/s00066-004-1315-1
36. CH Crane KO Macdonald JN Vauthey P Yehuda T Brown S Curley, et al. 2002 Limitations of conventional doses of chemoradiation for unresectable biliary cancer Int J Radiat Oncol Biol Phys. 53 969 974 12095564 10.1016/S0360-3016(02) 02845-6
37. F Deodato G Clemente GC Mattiucci G Macchia G Costamagna F Giuliante, et al. 2006 Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results Int J Radiat Oncol Biol Phys. 64 483 488 16242254 10.1016/j.ijrobp.2005. 07.977
38. AP Ghafoori JW Nelson CG Willett J Chino DS Tyler HI Hurwitz, et al. 2011 Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma Int J Radiat Oncol Biol Phys. 81 654 659 20864265 10.1016/j.ijrobp.2010.06.018
39. HA Burris 3rd MJ Moore J Andersen MR Green ML Rothenberg MR Modiano, et al. 1997 Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol. 15 2403 2413 9196156 1:CAS:528:DyaK2sXlsFKksLY%3D
40. D Cunningham I Chau DD Stocken JW Valle D Smith W Steward, et al. 2009 Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer J Clin Oncol. 27 5513 5518 19858379 10.1200/JCO.2009.24.2446 1:CAS:528:DC%2BC3cXhtVWitrc%3D
41. T Conroy F Desseigne M Ychou O Bouché R Guimbaud Y Bécouarn, et al. 2011 FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N Engl J Med. 364 1817 1825 21561347 10.1056/NEJMoa1011923 1:CAS:528:DC%2BC3MXlvF2jsrw%3D
42. HQ Xiong GR Varadhachary JC Blais KR Hess JL Abbruzzese RA Wolff 2008 Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer Cancer. 113 2046 2052 18756532 10.1002/cncr.23810 1:CAS:528:DC%2BD1cXht12lurfE
43. JP Neoptolemos DD Stocken C Bassi P Ghaneh D Cunningham D Goldstein, et al. 2010 Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial JAMA. 304 1073 1081 20823433 10.1001/jama.2010.1275 1:CAS:528: DC%2BC3cXhtFequ7nE
44. Pelzer U, Kubica K, Stieler J, Schwaner I, Heil G, Gorner M, et al. A randomized trial in patients with gemcitabine refractory pancreatic cancer. Final results of the CONKO 003 study. J Clin Oncol. 2008;26(May 20 suppl):Abstract 4508.
45. J Valle H Wasan DH Palmer D Cunningham A Anthoney A Maraveyas, et al. 2010 Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med. 362 1273 1281 20375404 10.1056/NEJMoa0908721 1:CAS:528: DC%2BC3cXksVyiuro%3D
46. AF Hezel AX Zhu 2008 Systemic therapy for biliary tract cancers Oncologist. 13 415 423 18448556 10.1634/theoncologist.2007-0252 1:CAS:528:DC%2BD1cXmslKksbo%3D
47. Y Zen F Pedica VR Patcha P Capelli G Zamboni A Casaril, et al. 2011 Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct Mod Pathol. 24 1079 1089 21516077 10.1038/modpathol.2011.71
48. Y Nakanishi Y Zen S Kondo T Itoh K Itatsu Y Nakanuma 2008 Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm Hum Pathol. 39 1153 1161 18495210 10.1016/j.humpath.2007.11.018 1:CAS:528: DC%2BD1cXptVKrs70%3D
49. K Itatsu Y Zen S Ohira A Ishikawa Y Sato K Harada, et al. 2007 Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis Liver Int. 27 1174 1184 17919228 10.1111/j.1478-3231.2007.01577.x
50. P Argani A Shaukat M Kaushal RE Wilentz GH Su TA Sohn, et al. 2001 Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts Cancer. 91 1332 1341 11283934 10.1002/1097-0142(20010401)91:7<1332::AID-CNCR1136>3.0.CO;2-4 1:CAS:528:DC%2BD3MXislyhtbs%3D
51. G Miller ND Socci D Dhall M D'Angelica RP DeMatteo PJ Allen, et al. 2009 Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract J Exp Clin Cancer Res. 28 62 19435499 10.1186/1756-9966-28-62
52. D Yoshikawa H Ojima M Iwasaki N Hiraoka T Kosuge S Kasai, et al. 2008 Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma Br J Cancer. 98 418 425 18087285 10.1038/sj.bjc.6604129 1:CAS:528:DC%2BD1cXhtVKjsr8%3D
53. K Nakazawa Y Dobashi S Suzuki H Fujii Y Takeda A Ooi 2005 Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers J Pathol. 206 356 365 15892172 10.1002/path.1779 1:CAS:528:DC%2BD2MXmvVartb0%3D
54. A Tannapfel F Sommerer M Benicke A Katalinic D Uhlmann H Witzigmann, et al. 2003 Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma Gut. 52 706 712 12692057 10.1136/gut.52.5.706 1:CAS:528:DC%2BD3sXjvVeiu7g%3D
55. JH Yoon NW Werneburg H Higuchi AE Canbay SH Kaufmann C Akgul, et al. 2002 Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism Cancer Res. 62 6500 6505 12438243 1:CAS:528:DC%2BD38XovFOksrw%3D
56. C Benckert S Jonas T Cramer Z Von Marschall G Schäfer M Peters, et al. 2003 Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells Cancer Res. 63 1083 1092 12615726 1:CAS:528:DC%2BD3sXhs1agtL4%3D
57. CD Briggs CP Neal CD Mann WP Steward MM Manson DP Berry 2009 Prognostic molecular markers in cholangiocarcinoma: a systematic review Eur J Cancer. 45 33 47 18938071 10.1016/j.ejca.2008.08.024 1:CAS:528:DC%2BD1cXhsFahur%2FP
58. AB El-Khoueiry CJ Rankin E Ben-Josef HJ Lenz PJ Gold RD Hamilton, et al. 2012 SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma Invest New Drugs. 30 1646 1651 21748296 10.1007/s10637-011-9719-0 1:CAS:528:DC%2BC38XpvVyksLc%3D
59. ME Alden M Mohiuddin 1994 The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer Int J Radiat Oncol Biol Phys. 28 945 951 8138448 10.1016/0360-3016(94)90115-5 1:STN:280:DyaK2c7os1eqtA%3D%3D
60. ML Foo LL Gunderson CE Bender SJ Buskirk 1997 External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma Int J Radiat Oncol Biol Phys. 39 929 935 9369143 10.1016/S0360-3016(97)00299-X 1:CAS:528:DyaK2sXnsVyqu7k%3D
61. BG Czito TJ Hong DP Cohen WP Petros DS Tyler TN Pappas, et al. 2006 A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract Cancer Invest. 24 9 17 16466986 10.1080/07357900500449454 1:CAS:528:DC%2BD28XhsVSmtbk%3D
62. TZ Vern-Gross AT Shivnani K Chen CM Lee JD Tward OK MacDonald, et al. 2011 Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis Int J Radiat Oncol Biol Phys. 81 189 198 20971573 10.1016/j.ijrobp.2010.05.001
63. M Fernandez-Ruiz JM Guerra-Vales F Colina-Ruizdelgado 2009 Comorbidity negatively influences prognosis in patients with extrahepatic cholangiocarcinoma World J Gastroenterol. 15 5279 5286 19908335 10.3748/wjg.15.5279
64. Y Sakamoto K Shimada S Nara M Esaki H Ojima T Sano, et al. 2010 Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients J Gastrointest Surg. 14 335 343 19902311 10.1007/s11605-009-1072-7
65. A Alexopoulou A Soultati SP Dourakis L Vasilieva AJ Archimandritis 2008 Cholangiocarcinoma: a 7-year experience at a single center in Greece World J Gastroenterol. 14 6213 6217 18985813 10.3748/wjg.14.6213
66. PJ Allen AS Reiner M Gonen DK Klimstra LH Blumgart MF Brennan, et al. 2008 Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions HPB (Oxford). 10 341 346 10.1080/13651820802276630
67. T Wakai Y Shirai Y Tsuchiya T Nomura K Akazawa K Hatakeyama 2008 Combined major hepatectomy and pancreaticoduodenectomy for locally advanced biliary carcinoma: long-term results World J Surg. 32 1067 1074 18231828 10.1007/s00268-007-9393-8
68. J Hernandez SM Cowgill S Al-Saadi D Villadolid S Ross E Kraemer, et al. 2008 An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection Ann Surg Oncol. 15 807 814 18181000 10.1245/s10434-007-9756-2
69. QF Shi TB Liang YS Qin WL Wang Y Shen M Zhang, et al. 2007 Evaluation of surgical approach for extrahepatic cholangiocarcinoma Hepatobiliary Pancreat Dis Int. 6 622 626 18086629
70. SM Woo JK Ryu SH Lee JW Yoo JK Park YT Kim, et al. 2007 Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma Ann Surg Oncol. 14 3195 3201 17710498 10.1245/s10434-007-9537-y
71. R Sasaki Y Takeda O Funato H Nitta H Kawamura N Uesugi, et al. 2007 Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma World J Surg. 31 1788 1796 17647056 10.1007/s00268-007-9102-7
72. T Wakai Y Shirai T Moroda N Yokoyama K Hatakeyama 2005 Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma Cancer. 103 1210 1216 15685618 10.1002/cncr.20906
73. D Blom SI Schwartz 2001 Surgical treatment and outcomes in carcinoma of the extrahepatic bile ducts: the University of Rochester experience Arch Surg. 136 209 215 11177143 10.1001/archsurg.136.2.209 1:STN:280:DC%2BD3M7ptlentw%3D%3D
74. A Nakeeb HA Pitt TA Sohn J Coleman RA Abrams S Piantadosi, et al. 1996 Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors Ann Surg. 224 463 473 8857851 10.1097/00000658-199610000-00005 1:STN:280: DyaK2s%2FhtVyiug%3D%3D discussion 473-5
75. DM Nagorney JH Donohue MB Farnell CD Schleck DM Ilstrup 1993 Outcomes after curative resections of cholangiocarcinoma Arch Surg. 128 871 877 8393652 10.1001/archsurg.1993.01420200045008 1:STN:280:DyaK3szktlOlsQ%3D%3D discussion 877-9
76. A Evander P Fredlund J Hoevels I Ihse S Bengmark 1980 Evaluation of aggressive surgery for carcinoma of the extrahepatic bile ducts Ann Surg. 191 23 29 6153259 10.1097/00000658-198001000-00005 1:STN:280:DyaL3c7gvVamuw%3D%3D